Perelman School of Medicine at the University of Pennsylvania

Amaravadi Lab

Header Image

We thank the patients and their family for their courage in joining clinical trials

HCQ Clinical Trials affiliated with UPENN that are open for accrual


Phase I/II trial of Dabrafenib, Trametinib+ HCQ ( BAMM trial) in BRAF mutant melanoma patients. [NCT02257424]

Colon Cancer

Phase I/II trial of FOLFOX/bevacizumab/HCQ in advanced colon cancer [NCT01206530]

Pancreatic cancer

Randomized phase II trial of gemcitabine+ abraxane + HCQ in advanced pancreatic cancer [NCT01506973]

Renal Cell Carcinoma

Phase I/II trial of everolimus and HCQ in patients with advanced renal cell carcinoma [NCT01510119]

Hepatocellular Carcinoma

Phase I/II trial of TACE and HCQ for HCC [NCT02013778]